Citadel Advisors
OGEN icon

Citadel Advisors’s Oragenics OGEN Stock Holding History

Citadel Advisors’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-550
Closed -$17.2K – 14934
2024
Q2 		$17.2K Buy
+550
New +$24.9K ﹤0.01% 12760
2023
Q1 		– Sell
-48
Closed -$9.11K – 15266
2022
Q4 		$9.11K Buy
+48
New +$16.9K ﹤0.01% 13707
2022
Q1 		– Sell
-30
Closed -$24K – 14291
2021
Q4 		$24K Sell
30
-45
-60% -$45.5K ﹤0.01% 13546
2021
Q3 		$86K Buy
+75
New +$90.5K ﹤0.01% 13009
2021
Q2 		– Sell
-206
Closed -$336K – 14192
2021
Q1 		$336K Buy
206
+90
+78% +$163K ﹤0.01% 10572
2020
Q4 		$94K Buy
116
+96
+480% +$84.5K ﹤0.01% 10261
2020
Q3 		$21K Buy
+20
New +$32K ﹤0.01% 9844
2018
Q4 		– Sell
-17
Closed -$35K – 9583
2018
Q3 		$35K Buy
+17
New +$19.6K ﹤0.01% 8890
2018
Q1 		– Sell
-2
Closed -$10K – 8626
2017
Q4 		$10K Buy
+2
New +$12.6K ﹤0.01% 7893
2017
Q3 		– Sell
-3
Closed -$18K – 7877
2017
Q2 		$18K Buy
3
+1
+50% +$7.41K ﹤0.01% 7306
2017
Q1 		$13K Buy
+2
New +$21.5K ﹤0.01% 7325
2016
Q3 		– Sell
-2
Closed -$17K – 7596
2016
Q2 		$17K Buy
2
+1
+100% +$13.4K ﹤0.01% 6667
2016
Q1 		$13K Buy
+1
New +$18.3K ﹤0.01% 6570
2015
Q2 		– Sell
-1
Closed -$17K – 8962
2015
Q1 		$17K Hold
1
– – ﹤0.01% 8014
2014
Q4 		$16K Hold
1
– – ﹤0.01% 7957
2014
Q3 		$18K Buy
+1
New +$29.8K ﹤0.01% 7525
2014
Q2 		– Sell
-1
Closed -$54K – 8195
2014
Q1 		$54K Buy
+1
New +$60.7K ﹤0.01% 6721

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
LWM
Lionsbridge Wealth Management Jacksonville Beach, Florida $102M AUM 28.57% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citadel Advisors's OGEN Position: Q3 2024 in Review

Citadel Advisors sold out of Oragenics (OGEN) in Q3 2024, closing a stake of 550 shares — an estimated $17.2K sold.

Citadel Advisors first reported a position in OGEN in Q1 2014 and held it in 17 quarters. The position peaked at $336K in Q1 2021. 13 funds tracked by Wall St. Rank hold OGEN as of Q3 2024.

  • Citadel Advisors reported no remaining Oragenics position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 550 Oragenics shares in Q3 2024, an estimated $17.2K.
  • Citadel Advisors first reported a position in Oragenics in Q1 2014 and held it in 17 quarters.
  • Citadel Advisors's Oragenics position peaked at $336K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Oragenics as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.